Philippa Hetherington Remembered
We had to confirm back on the 5th November the heartbreaking news that the wonderful Philippa Hetherington had died 💔 She was an absolute force of intellectual nature for breast cancer in general,…
Read more
Research news
Articles filed under Research.
Articles
METUPUK are delighted for the approval of Trastuzumab deruxtecan (Enhertu) for second line use.
*METUPUK are delighted for the approval of Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received one or more prior anti-HER2…
Read more
Trodelvy Now! Latest Update
METUPUK are delighted that NICE has accepted Trodelvy (sacituzumab govitecan) for routine use on the NHS in England for the treatment of patients with unresectable locally advanced or metastatic…
Read more
Why we need MBC research more than ever
At METUPUK, we dream of the day when metastatic breast cancer (MBC) is downgraded from an incurable to a chronic illness. The only way this will be possible is through new scientific research. We…
Read more
A #TrodelvyNow Update
Following on from our #TrodelvyNow post last month, MetUpUk Member Phillippa has appeared in the Daily Mail, alongside other women for who this drug could mean, literally the difference between life…
Read more
#TrodelvyNow!
Of all the subtypes of metastatic breast cancer, metastatic Triple Negative Breast Cancer (TNBC) is the hardest to treat with the worst prognosis. While new advances in the treatment of hormone…
Read more
Statistics for Metastatic Breast Cancer
We started our campaign in Metastatic May with some information about treatment lines and it really caused a bit of a stir, especially on Instagram. Why? Because people don’t want to think that this…
Read more
A Real Life Accounts of Accessing Clinical Trials
In 2018 I was diagnosed with secondary breast cancer in my liver, I was 44. I knew the survival statistics were grim, so decided from the outset, in order to outlive the 2 to 3-year median I’d have…
Read more
Aren’t you a bit young to have a pacemaker
Stage 4 breast cancer with a pacemaker Most people know someone with a pacemaker, and chances are that person will be elderly. The average age of a first pacemaker implantation in the UK is 72, but…
Read more
Why do we use a ‘fingers crossed’ approach to treating advanced cancer?
I remember first hearing about genomics testing for cancer, about a year after my diagnosis of secondary breast cancer. I had failed on every line of treatment I’d been given, was fast running out of…
Read more
‘The lingering mysteries of metastatic recurrence in breast cancer’ in @BrJCancer
Abstract: Despite being the hallmark of cancer that is responsible for the highest number of deaths, very little is known about the biology of metastasis. Metastatic disease typically manifests after…
Read more
The researchers who make a difference to MBC patients
We thought you would like to hear about what it is like to work in metastatic breast cancer research. Here, we chat to Dr Rachel Eyre who works at The Manchester Cancer Research Centre about her life…
Read more